REG - Assura plc - Trading Update

AssuraAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250930:nRSd2726Ba&default-theme=true

RNS Number : 2726B  Assura PLC  30 September 2025

30 September 2025

Assura plc

Trading update for the first half ended 30 September 2025

Assura plc ("Assura"), the UK's leading diversified healthcare REIT, today
announces its Trading Update for the first half to 30 September 2025, in
advance of the annual general meeting being held later today.

Jonathan Murphy, CEO, said:

"I am proud to report on a strong trading performance over the first six
months of the financial year, in what was a period of uncertainty for the
business. This is testament to the hard work and dedication of our team
members, the strength of Assura's business, and the vital role we play within
the UK healthcare infrastructure.

 

"We have delivered strong rental growth, which has flowed into the positive
property valuation uplift, and have continued to identify opportunities to
deliver new healthcare developments for both the NHS and independent sector.

 

"There remains critical need for investment in healthcare buildings to enable
the provision of high-quality health services. Assura's specialist team has
the skills and expertise to partner with our customers to meet these needs."

 

Continued track record of delivery to enhance portfolio value and earnings

•     Rent reviews completed in the first half generated:

o  Like-for-like increase of 5.6% on £25.5 million of rent roll reviewed

o  Weighted average annual uplift of 2.9%

•     Annual equivalent uplift of 2.7% on OMR reviews, 3.0% on RPI and
other

•     15 asset enhancement lease events (renewals, regears and net
lettings) completed covering £1.0 million of rent roll, adding 11 years on
average to those leases

•     Commenced roll out of rooftop solar commercialisation project

o  First installation at Crompton Health Centre in Bolton fully energised and
moving on site with a further 10 sites by December

o  Each installation will generate a significant reduction in carbon
emissions, reduce energy costs for tenants and generate an attractive
investment yield

o  Total spend on the first projects is expected to be £1 million, with a
pipeline of further 40 future schemes now under detailed review

 

Ongoing development activity

•     Construction underway on a £18 million primary care scheme in
Weston-Super-Mare pre-let to the NHS on a 25 year lease subject to 5 yearly
CPIH rent reviews. This is the first development funded through the £250
million joint venture with USS

•     Construction to commence shortly on a new £19 million independent
hospital in Peterborough pre-let to a tier one independent health provider on
a 25 year lease subject to 3 yearly RPI rent reviews

•     Agreements to commence £7 million extension on two existing
independent hospital sites to provide further on-site clinical capacity

•     Three existing on site developments in Ireland continue to
progress well (total cost £31 million of which £17 million has been spent to
date)

 

Attractive pipeline of opportunities to support health care system

•     £250 million development pipeline capable of commencing in the
next 2 years

o  £160 million of large independent sector projects

o  £90 million of NHS primary care schemes

•     31 asset enhancement lease events covering £5.6 million of
existing rent roll in the current pipeline

 

Portfolio positioned to deliver strong future cash flows

•     Portfolio now stands at 602 properties with an annualised rent
roll of £179.5 million (March 2025: 603. £177.9 million) and a WAULT of 12.3
years (March 2025: 12.7 years)

•     Following active portfolio management, portfolio rent reviews
consist of: c.54% OMR, c.46% indexed, fixed or other

•     Highest-ever admissions into the independent sector generating
record growth in our private hospitals operational profitability, improving
rent cover to 2.6x from 2.3x

•     Portfolio management activities and rent reviews have contributed
to valuation uplift of approximately £12 million in the first half. Portfolio
Net Initial Yield 5.23% (March 2025: 5.21%)

 

Primary Health Properties PLC ("PHP") offer for Assura and delisting from the
London Stock Exchange ("LSE") and Johannesburg Stock Exchange ("JSE")

On 5 September 2025, at the request of PHP, Assura made requests to the FCA
and the London Stock Exchange respectively to cancel the listing and trading
of the Assura Shares on the Equity Shares (Commercial Companies) category of
the Official List and Main Market of the LSE (the "LSE Delisting"). It is
anticipated that the LSE Delisting will take effect no earlier than 7.30 a.m.
on 6 October 2025.

 

Trading of Assura's Shares on the Main Board of the JSE is expected to be
suspended from 7.30 a.m. (South African Standard Time) on 3 October 2025. The
cancellation of the listing and trading of the Assura Shares on the Main Board
of the JSE is expected to take place on 23 October 2025.

 

Please refer the announcements on Assura's website for further information on
the delisting and offer from PHP.

 

- Ends -

 

For more information, please contact:

 Assura plc                                   Tel: 0161 515 2043
 Jayne Cottam, CFO                            Email: Investor@assura.co.uk
 David Purcell, Investor Relations Director
 FGS Global                                   Tel: 0207 251 3801

                                            Email: Assura-LON@fgsglobal.com
 Gordon Simpson

Grace Whelan

 

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables
better health outcomes through its portfolio of more than 600 healthcare
buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is currently a constituent of the EPRA*
index and has a secondary listing on the Johannesburg Stock Exchange. As at 31
March 2025, Assura's portfolio was valued at £3.1 billion and has a strong
track record of growing financial returns and dividends for shareholders.

At Assura we BUILD for health and as a certified B Corp we are committed to
keeping ESG as the heart of our strategy, creating Healthy Environments (E),
Healthy Communities (S) and maintaining a Healthy Business (G).

Further information is available at www.assuraplc.com
(http://www.assuraplc.com)

*EPRA is a registered trademark of the European Public Real Estate Association
CPIH is Consumer Prices Index including owner occupiers' housing costs

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTFLFVEALIAFIE